Olrace CH 20mg/12.5mg Tablet
By Olrace CH
Rx
10 Tablet in a Strip

Composition
Olmesartan Medoxomil(20mg) + Chlorthalidone(12.5mg)

Manufacturer - Hemera Life Sciences Private Limited
4626, Ground floor, 4th main 3rd cross SS Layout B Block DAVANGERE Davanagere KA 577004 India

Expires on or after
December, 2026

liver
When it comes to using Olrace CH 20mg/12.5mg Tablet, it's important to be cautious if you have liver disease. Patients with liver issues may require adjustments in the dosage of this tablet. It is highly advised to consult your doctor before using this medication if you have any liver concerns. Remember that Olrace CH 20mg/12.5mg Tablet is not recommended for individuals with severe liver disease. Prioritize your liver health and seek professional medical advice to ensure safe usage of this medication.

kidney
Olrace CH 20mg/12.5mg Tablet requires caution in severe kidney disease. Adjustments in dosage may be necessary. It is not recommended for these patients; consult your doctor.

alcohol
When taking Olrace CH 20mg/12.5mg Tablet, be cautious as it may lead to increased drowsiness when consumed with alcohol.

driving
When taking Olrace CH 20mg/12.5mg Tablet, be cautious as it may reduce alertness, impact vision, or cause drowsiness and dizziness. It is advised not to drive if experiencing these effects.

pregnancy
During pregnancy, avoid using Olrace CH 20mg/12.5mg Tablet as it can harm the developing baby. However, in life-threatening situations, a doctor might prescribe it if benefits outweigh risks. Always consult your doctor.

breastfeeding
Caution is advised when breastfeeding while taking Olrace CH 20mg/12.5mg Tablet, as it may be unsafe for the baby due to potential transfer of the drug through breastmilk.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | CARDIAC |
| Action Class | - |
₹94.35
₹111
15% OFF
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024
